Published in Leukemia on February 11, 2010
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chin J Cancer (2011) 1.30
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein. Proc Natl Acad Sci U S A (2010) 1.24
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia. PLoS One (2013) 0.99
OCT1 and imatinib transport in CML: is it clinically relevant? Leukemia (2015) 0.84
OCT-1 function varies with cell lineage but is not influenced by BCR-ABL. Haematologica (2010) 0.83
OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib. Chonnam Med J (2014) 0.82
Dasatinib targets chronic myeloid leukemia-CD34+ progenitors as effectively as it targets mature cells. Haematologica (2012) 0.80
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib. J Hematol Oncol (2015) 0.78
Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era. Am J Blood Res (2013) 0.76
MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients. Blood Cancer J (2016) 0.75
Selection of therapy: rational decisions based on molecular events. Hematol Oncol Clin North Am (2011) 0.75
Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy. Int J Clin Oncol (2017) 0.75
Historical overfishing and the recent collapse of coastal ecosystems. Science (2001) 33.78
Confronting the coral reef crisis. Nature (2004) 14.36
Catastrophes, phase shifts, and large-scale degradation of a Caribbean coral reef. Science (1994) 12.98
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Ecology. Are U.S. coral reefs on the slippery slope to slime? Science (2005) 6.98
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia (2009) 6.29
Ecology. Globalization, roving bandits, and marine resources. Science (2006) 5.88
Regional-scale assembly rules and biodiversity of coral reefs. Science (2001) 4.88
Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol (1989) 3.59
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging (1992) 2.97
Do corals lie about their age? Some demographic consequences of partial mortality, fission, and fusion. Science (1980) 2.84
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up. Leukemia (2012) 2.80
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia (2012) 2.78
Genotypic diversity and gene flow in brooding and spawning corals along the Great Barrier Reef, Australia. Evolution (2000) 2.28
Hemagglutination and colonization factors in enterotoxigenic and enteropathogenic Escherichia coli that cause diarrhea. J Infect Dis (1980) 2.26
Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. Environ Health Perspect (1999) 2.21
Growth and survival of streptomycete inoculants and extent of plasmid transfer in sterile and nonsterile soil. Appl Environ Microbiol (1990) 2.04
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia (2010) 1.97
The Inheritance of Susceptibility to Yellow Fever Encephalitis in Mice. Genetics (1936) 1.92
Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem (1991) 1.70
THE EPIDEMIOLOGY OF PNEUMOCOCCUS INFECTION : THE INCIDENCE AND SPREAD OF PNEUMOCOCCI IN THE NASAL PASSAGES AND THROATS OF HEALTHY PERSONS. J Exp Med (1931) 1.67
Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics. Br J Haematol (1999) 1.58
Energy-linked electron transfer reactions in Rhodopseudomonas viridis. Biochim Biophys Acta (1972) 1.52
THE EPIDEMIOLOGY OF FOWL CHOLERA : IV. FIELD OBSERVATIONS OF THE "SPONTANEOUS" DISEASE. J Exp Med (1930) 1.52
Hypergammaglobulinemia and the anticardiolipin antibody test. Arthritis Rheum (1989) 1.51
Comparison of simple sugar/salt versus glucose/electrolyte oral rehydration solutions in infant diarrhoea. J Trop Med Hyg (1981) 1.46
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study. Leukemia (2012) 1.44
Genetic susceptibility to cholera. Ann Hum Biol (1980) 1.44
Creation of a gilded trap by the high economic value of the Maine lobster fishery. Conserv Biol (2011) 1.41
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma. Leukemia (2011) 1.39
Lack of person-to-person transmission of enterotoxigenic Escherichia coli despite close contact. Am J Epidemiol (1980) 1.34
Deletion and rearrangement of plasmid DNA during transformation of Escherichia coli with linear plasmid molecules. Nucleic Acids Res (1986) 1.30
Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood (1993) 1.30
Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. J Cell Physiol (2010) 1.26
Mechanism of intramolecular recyclization and deletion formation following transformation of Escherichia coli with linearized plasmid DNA. Nucleic Acids Res (1986) 1.26
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scand J Infect Dis Suppl (1982) 1.26
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Leukemia (2003) 1.23
Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally. Infect Immun (1978) 1.22
Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol (1993) 1.18
Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Radiology (1990) 1.18
Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL. Leukemia (2006) 1.15
A chemical mechanism for tissue staining by osmium tetroxide-ferrocyanide mixtures. J Histochem Cytochem (1979) 1.11
Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.11
Disaturated and dipolyunsaturated phospholipids in the bovine retinal rod outer segment disk membrane. Biochim Biophys Acta (1979) 1.11
Streptomyces marker plasmids for monitoring survival and spread of streptomycetes in soil. Appl Environ Microbiol (1991) 1.11
Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. Am J Epidemiol (1981) 1.08
Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy. Leukemia (2009) 1.07
The chemical nature of osmium tetroxide fixation and staining of membranes by x-ray photoelectron spectroscopy. Biochim Biophys Acta (1976) 1.06
Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther (2008) 1.06
Genetics of Rhodospirillaceae. Microbiol Rev (1978) 1.05
Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors. Leukemia (2010) 1.05
Extrachromosomal deoxyribonucleic acid in wild-type and photosynthetically incompetent strains of Rhodopseudomonas spheroides. J Bacteriol (1976) 1.05
Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med (1993) 1.04
Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer (2013) 1.02
Kinetic and thermodynamic properties of membrane-bound cytochromes of aerobically and photosynthetically grown Rhodopseudomonas spheroides. Biochim Biophys Acta (1973) 1.01
Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone (2002) 1.01
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value. Leukemia (2009) 1.00
Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance. Leukemia (2012) 0.98
Ultrafast magnetic resonance imaging: diffusion and perfusion. Can Assoc Radiol J (1991) 0.98
Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA. Int J Lab Hematol (2010) 0.97
The asymmetric transmembrane distribution of phosphatidylethanolamine, phosphatidylserine, and fatty acids of the bovine retinal rod outer segment disk membrane. J Membr Biol (1981) 0.97
Do we have to kill the last CML cell? Leukemia (2010) 0.97
Oxidative phosphorylation and effects of aerobic conditions on Rhodopseudomonas viridis. Biochim Biophys Acta (1973) 0.97
Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche? Blood Cancer J (2012) 0.96
Short-term intense Bcr-Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL(+) cells. Leukemia (2009) 0.96
Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever. J Infect Dis (1983) 0.95
NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis. Leukemia (2012) 0.95
Hypercarbia-induced changes in cerebral blood volume in the cat: a 1H MRI and intravascular contrast agent study. Magn Reson Med (1992) 0.94
Reactogenicity and immunogenicity of parenteral monovalent influenza A/Victoria/3/75 (H3N2) virus vaccine in healthy adults. J Infect Dis (1977) 0.94
Properties of the cytochrome a-like material developed in the photosynthetic bacterium Rhodopseudomonas spheroides when grown aerobically. Biochim Biophys Acta (1974) 0.93
Stereoscopic MR imaging. J Comput Assist Tomogr (1989) 0.93
Microdissection and chromosome painting of plant B chromosomes. Methods Cell Sci (2001) 0.93
Imatinib mesylate causes growth plate closure in vivo. Leukemia (2009) 0.92
Therapeutic concentrations of dasatinib inhibit in vitro osteoclastogenesis. Leukemia (2008) 0.92
Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells. Leukemia (2010) 0.92
Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34-35, a region frequently affected in haematological neoplasms. Hum Genet (1995) 0.91
Use of the venereal disease clinic of San Mateo County, California. Public Health Rep (1968) 0.90
Cancer treatment with kinase inhibitors: what have we learnt from imatinib? Br J Cancer (2004) 0.90
Faunal breaks and species composition of Indo-Pacific corals: the role of plate tectonics, environment and habitat distribution. Proc Biol Sci (2013) 0.89
Obstructive sleep apnea treatment outcomes pilot study. Otolaryngol Head Neck Surg (1998) 0.89
Exogenous lactobacilli fed to man - their fate and ability to prevent diarrheal disease. Prog Food Nutr Sci (1983) 0.89
OCT-1 activity measurement provides a superior imatinib response predictor than screening for single-nucleotide polymorphisms of OCT-1. Leukemia (2010) 0.89
Rule-based simulation of temperate bacteriophage infection: restriction-modification as a limiter to infection in bacterial populations. Biosystems (2010) 0.88
BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistance. Br J Cancer (2013) 0.88
Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes. Brain Res (1994) 0.87
Accumulation of gentamicin by Staphylococcus aureus: the role of the transmembrane electrical potential. J Antimicrob Chemother (1986) 0.87
Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha. Cancer Res (1990) 0.87
Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus (2009) 0.87